LIDOCAINE VISCOUS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lidocaine Viscous, and when can generic versions of Lidocaine Viscous launch?
Lidocaine Viscous is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in LIDOCAINE VISCOUS is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lidocaine Viscous
A generic version of LIDOCAINE VISCOUS was approved as lidocaine hydrochloride by WOCKHARDT BIO AG on November 18th, 1982.
Summary for LIDOCAINE VISCOUS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Clinical Trials: | 12 |
| Patent Applications: | 5 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for LIDOCAINE VISCOUS |
| DailyMed Link: | LIDOCAINE VISCOUS at DailyMed |
Recent Clinical Trials for LIDOCAINE VISCOUS
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bispebjerg Hospital | Phase 4 |
| National Cancer Institute, Egypt | Early Phase 1 |
| Lawrence Charles Hookey | N/A |
Pharmacology for LIDOCAINE VISCOUS
| Drug Class | Amide Local Anesthetic Antiarrhythmic |
| Physiological Effect | Local Anesthesia |
Anatomical Therapeutic Chemical (ATC) Classes for LIDOCAINE VISCOUS
US Patents and Regulatory Information for LIDOCAINE VISCOUS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | LIDOCAINE VISCOUS | lidocaine hydrochloride | SOLUTION;ORAL | 088802-001 | Apr 26, 1985 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
